PRENATAL EXPOSURE TO TYLENOL LINKED TO SMALLER OVARIES IN FEMALE INFANTS

A new study has found that female infants exposed to paracetamol (Tylenol) in the womb exhibited reduced ovarian development compared with unexposed infants. Researchers evaluated 302 three-month-old female infants and tracked a separate cohort of 1,210 girls into adolescence. Three-month-old girls with prenatal exposure showed, on average, a 40 per cent reduction in ovarian volume, a 13 per cent smaller uterine volume, and 23 per cent fewer ovarian follicles. Lead author Margit Bistrup Fischer stated that the findings do not prove causation or demonstrate future fertility impacts, and advised pregnant women against alarm.

The study noted significant variation in individual outcomes, with many exposed infants exhibiting normal ovarian dimensions. Current medical guidelines continue to recommend paracetamol as a safe treatment for pain and fever during pregnancy, on the basis that untreated severe symptoms carry substantial health risks to the mother and developing foetus. Researchers emphasised that their findings do not alter existing clinical guidance on medication use in pregnancy.

The research contributes to ongoing examination of prenatal drug exposure and infant development. Bistrup Fischer cautioned that further investigation is required before drawing conclusions about long-term reproductive health. Medical authorities stated they will continue monitoring evidence as additional studies emerge, whilst maintaining current recommendations pending conclusive evidence of harm.